Arkolith/Insider Trading/RVNC/Form 4

Moxie Dwight

SVP, GC & SecretaryRevance Therapeutics, Inc. (RVNC) · full profile →Form 4 · filed Sep 7, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$612K
Net Open-Market Flow
-$612K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 6, 2023Sell(S)11K$17.06$188K44K
Sep 5, 2023Sell(S)24K$17.81$425K55K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001479290-23-000102) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML